BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16327935)

  • 1. [The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.].
    Machado SH; von Mühlen CA; Brenol JC; Bisotto L; Xavier RM
    J Pediatr (Rio J); 2005; 81(6):491-4. PubMed ID: 16327935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis].
    Machado SH; von Mühlen CA; Brenol JC; Bisotto L; Xavier RM
    J Pediatr (Rio J); 2005; 81(6):491-4. PubMed ID: 16385368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Avcin T; Cimaz R; Falcini F; Zulian F; Martini G; Simonini G; Porenta-Besic V; Cecchini G; Borghi MO; Meroni PL
    Ann Rheum Dis; 2002 Jul; 61(7):608-11. PubMed ID: 12079901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Habib HM; Mosaad YM; Youssef HM
    Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
    Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
    van Rossum M; van Soesbergen R; de Kort S; ten Cate R; Zwinderman AH; de Jong B; Dijkmans B; van Venrooij WJ
    J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
    Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
    Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cyclic citrullinated peptide antibodies in adult patients with juvenile idiopathic arthritis.
    Skare TS; Nisihara RM; Silva RM; Munhoz da Silva DJ; Gameiro Silva MB; Utiyama SR
    J Clin Rheumatol; 2011 Dec; 17(8):421-3. PubMed ID: 22089992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
    Zhang L; Ru J; Jie X; Che G; Jin X; Li X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Lipinska J; Lipinska S; Kasielski M; Smolewska E
    Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.
    Al-Jarallah K; Shehab D; Al-Attiyah R; Al-Azmi W; Al-Fadli A; Zafar Haider M; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2012 Sep; 18(9):1655-62. PubMed ID: 22114016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Hromadnikova I; Stechova K; Pavla V; Hridelova D; Houbova B; Voslarova S; Nekvasilova H; Vavrinec J
    Autoimmunity; 2002 Sep; 35(6):397-401. PubMed ID: 12568120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
    Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
    Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.